Yoga to Reduce Fatigue in Hospitalized Children Receiving Intensive Chemotherapy
Fatigue

About this trial
This is an interventional treatment trial for Fatigue focused on measuring fatigue, quality of life, chemotherapy, haematopoietic stem cell transplantation, children, pilot, yoga
Eligibility Criteria
Inclusion Criteria:
- Diagnosed with any acute myeloid leukemia (AML), relapsed acute lymphoblastic leukemia, stage 3 or 4 Burkitt's lymphoma/leukemia or about to receive autologous or allogeneic haematopoietic stem cell transplantation (HSCT)
- Expected to be an inpatient for at least three weeks after initiation of chemotherapy or conditioning
- Ages 7 to 18 years of age at enrollment
Exclusion Criteria:
- Features present to an extent that would preclude compliance with yoga (as assessed by the attending physician): a) motor disability, b) cognitive disability, c) cardiopulmonary symptoms, or d) known compression fracture resulting in disability
- Parent or patient cannot understand English
Sites / Locations
- The Hospital for Sick Children
Arms of the Study
Arm 1
Experimental
Individualized Yoga Intervention
Individualized Yoga Intervention sessions will be administered by a trained yoga instructor three times weekly (or up to a maximum of five times per week) for three consecutive weeks. There will be a common structure for all sessions that will include relaxation and breathing exercises as well as a series of poses focused on strengthening, flexibility, and balance. There will be low, moderate and high intensity regimens prescribed depending on the wishes and abilities of the child and parent and the judgment of the yoga instructor.